nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentamidine—CYP4A11—Rifampicin—leprosy	0.396	0.457	CbGbCtD
Pentamidine—CYP1A1—Thalidomide—leprosy	0.0745	0.086	CbGbCtD
Pentamidine—CYP3A5—Thalidomide—leprosy	0.0447	0.0516	CbGbCtD
Pentamidine—CYP3A5—Rifampicin—leprosy	0.0433	0.05	CbGbCtD
Pentamidine—CYP2C8—Rifampicin—leprosy	0.0417	0.0481	CbGbCtD
Pentamidine—CYP2C19—Thalidomide—leprosy	0.0361	0.0416	CbGbCtD
Pentamidine—CYP3A5—Dapsone—leprosy	0.0358	0.0413	CbGbCtD
Pentamidine—CYP2C19—Rifampicin—leprosy	0.035	0.0403	CbGbCtD
Pentamidine—CYP2C8—Dapsone—leprosy	0.0344	0.0397	CbGbCtD
Pentamidine—CYP1A2—Thalidomide—leprosy	0.0333	0.0384	CbGbCtD
Pentamidine—CYP1A2—Rifampicin—leprosy	0.0323	0.0372	CbGbCtD
Pentamidine—CYP2C19—Dapsone—leprosy	0.0289	0.0333	CbGbCtD
Pentamidine—CYP3A4—Rifampicin—leprosy	0.0169	0.0195	CbGbCtD
Pentamidine—CYP3A4—Dapsone—leprosy	0.0139	0.0161	CbGbCtD
Pentamidine—S100B—peripheral nervous system—leprosy	0.00779	0.263	CbGeAlD
Pentamidine—S100B—nerve—leprosy	0.00607	0.205	CbGeAlD
Pentamidine—S100B—blood vessel—leprosy	0.00477	0.161	CbGeAlD
Pentamidine—S100B—eye—leprosy	0.00254	0.0857	CbGeAlD
Pentamidine—Rales—Thalidomide—leprosy	0.00233	0.0276	CcSEcCtD
Pentamidine—S100B—skin of body—leprosy	0.00221	0.0745	CbGeAlD
Pentamidine—Raised liver function tests—Thalidomide—leprosy	0.00207	0.0246	CcSEcCtD
Pentamidine—Skin exfoliation—Dapsone—leprosy	0.00178	0.0211	CcSEcCtD
Pentamidine—Gastric ulcer—Thalidomide—leprosy	0.00164	0.0195	CcSEcCtD
Pentamidine—Inappropriate antidiuretic hormone secretion—Thalidomide—leprosy	0.00164	0.0195	CcSEcCtD
Pentamidine—S100B—TAK1 activates NFkB by phosphorylation and activation of IKKs complex—RIPK2—leprosy	0.00164	0.0849	CbGpPWpGaD
Pentamidine—AOC1—testis—leprosy	0.0016	0.0539	CbGeAlD
Pentamidine—Serum creatinine increased—Thalidomide—leprosy	0.00155	0.0184	CcSEcCtD
Pentamidine—CYP1A1—skin epidermis—leprosy	0.00154	0.052	CbGeAlD
Pentamidine—Hypomagnesaemia—Thalidomide—leprosy	0.0015	0.0179	CcSEcCtD
Pentamidine—Oral candidiasis—Thalidomide—leprosy	0.0015	0.0179	CcSEcCtD
Pentamidine—S100B—TAK1 activates NFkB by phosphorylation and activation of IKKs complex—NOD2—leprosy	0.00148	0.0769	CbGpPWpGaD
Pentamidine—Neuralgia—Thalidomide—leprosy	0.00138	0.0163	CcSEcCtD
Pentamidine—S100B—nervous system—leprosy	0.00137	0.0461	CbGeAlD
Pentamidine—Hepatomegaly—Thalidomide—leprosy	0.00135	0.016	CcSEcCtD
Pentamidine—Interstitial lung disease—Thalidomide—leprosy	0.00135	0.016	CcSEcCtD
Pentamidine—Cyanosis—Thalidomide—leprosy	0.00135	0.016	CcSEcCtD
Pentamidine—Lung disorder—Thalidomide—leprosy	0.00135	0.016	CcSEcCtD
Pentamidine—Psychotic disorder—Dapsone—leprosy	0.00132	0.0157	CcSEcCtD
Pentamidine—Influenza—Dapsone—leprosy	0.00117	0.0139	CcSEcCtD
Pentamidine—Pancreatitis—Dapsone—leprosy	0.00115	0.0136	CcSEcCtD
Pentamidine—Hypocalcaemia—Thalidomide—leprosy	0.00104	0.0124	CcSEcCtD
Pentamidine—S100B—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—CYLD—leprosy	0.00103	0.0536	CbGpPWpGaD
Pentamidine—Neuropathy peripheral—Dapsone—leprosy	0.00102	0.0121	CcSEcCtD
Pentamidine—Creatinine increased—Thalidomide—leprosy	0.001	0.0119	CcSEcCtD
Pentamidine—Sinusitis—Dapsone—leprosy	0.00098	0.0116	CcSEcCtD
Pentamidine—Gait disturbance—Thalidomide—leprosy	0.000979	0.0116	CcSEcCtD
Pentamidine—Hyperkalaemia—Thalidomide—leprosy	0.000939	0.0111	CcSEcCtD
Pentamidine—Pharyngitis—Dapsone—leprosy	0.00093	0.011	CcSEcCtD
Pentamidine—Colitis—Thalidomide—leprosy	0.000917	0.0109	CcSEcCtD
Pentamidine—Skin exfoliation—Thalidomide—leprosy	0.000912	0.0108	CcSEcCtD
Pentamidine—Candida infection—Thalidomide—leprosy	0.000912	0.0108	CcSEcCtD
Pentamidine—Blood urea increased—Thalidomide—leprosy	0.000902	0.0107	CcSEcCtD
Pentamidine—Neuropathy—Thalidomide—leprosy	0.000897	0.0106	CcSEcCtD
Pentamidine—Lightheadedness—Thalidomide—leprosy	0.000855	0.0101	CcSEcCtD
Pentamidine—Sepsis—Thalidomide—leprosy	0.000829	0.00984	CcSEcCtD
Pentamidine—Erythema—Dapsone—leprosy	0.000816	0.00968	CcSEcCtD
Pentamidine—Diabetes mellitus—Thalidomide—leprosy	0.000797	0.00946	CcSEcCtD
Pentamidine—Vision blurred—Dapsone—leprosy	0.000769	0.00913	CcSEcCtD
Pentamidine—Eye pain—Thalidomide—leprosy	0.000768	0.00912	CcSEcCtD
Pentamidine—Renal failure acute—Thalidomide—leprosy	0.000751	0.00892	CcSEcCtD
Pentamidine—Amnesia—Thalidomide—leprosy	0.000738	0.00876	CcSEcCtD
Pentamidine—Vertigo—Dapsone—leprosy	0.000733	0.0087	CcSEcCtD
Pentamidine—Cough—Dapsone—leprosy	0.000712	0.00845	CcSEcCtD
Pentamidine—Hypoglycaemia—Thalidomide—leprosy	0.000711	0.00844	CcSEcCtD
Pentamidine—Lethargy—Thalidomide—leprosy	0.000708	0.0084	CcSEcCtD
Pentamidine—Cerebrovascular accident—Thalidomide—leprosy	0.000708	0.0084	CcSEcCtD
Pentamidine—S100B—TRAF6 Mediated Induction of proinflammatory cytokines—RIPK2—leprosy	0.000702	0.0364	CbGpPWpGaD
Pentamidine—Affect lability—Thalidomide—leprosy	0.000683	0.0081	CcSEcCtD
Pentamidine—Psychotic disorder—Thalidomide—leprosy	0.000677	0.00804	CcSEcCtD
Pentamidine—Face oedema—Thalidomide—leprosy	0.00067	0.00795	CcSEcCtD
Pentamidine—Mood swings—Thalidomide—leprosy	0.000657	0.0078	CcSEcCtD
Pentamidine—Tachycardia—Dapsone—leprosy	0.00065	0.00771	CcSEcCtD
Pentamidine—Blood creatinine increased—Thalidomide—leprosy	0.00065	0.00771	CcSEcCtD
Pentamidine—Liver function test abnormal—Thalidomide—leprosy	0.00064	0.0076	CcSEcCtD
Pentamidine—S100B—TRAF6 Mediated Induction of proinflammatory cytokines—NOD2—leprosy	0.000636	0.033	CbGpPWpGaD
Pentamidine—Dry skin—Thalidomide—leprosy	0.000636	0.00755	CcSEcCtD
Pentamidine—S100B—MyD88 cascade initiated on plasma membrane—RIPK2—leprosy	0.000635	0.0329	CbGpPWpGaD
Pentamidine—S100B—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RIPK2—leprosy	0.000629	0.0326	CbGpPWpGaD
Pentamidine—S100B—MyD88 dependent cascade initiated on endosome—RIPK2—leprosy	0.000617	0.032	CbGpPWpGaD
Pentamidine—Insomnia—Dapsone—leprosy	0.000602	0.00715	CcSEcCtD
Pentamidine—Influenza—Thalidomide—leprosy	0.000599	0.00711	CcSEcCtD
Pentamidine—S100B—Toll Like Receptor 9 (TLR9) Cascade—RIPK2—leprosy	0.000596	0.0309	CbGpPWpGaD
Pentamidine—Eosinophilia—Thalidomide—leprosy	0.000594	0.00704	CcSEcCtD
Pentamidine—Bronchospasm—Thalidomide—leprosy	0.00059	0.007	CcSEcCtD
Pentamidine—Pancreatitis—Thalidomide—leprosy	0.000588	0.00698	CcSEcCtD
Pentamidine—S100B—MyD88:Mal cascade initiated on plasma membrane—TLR2—leprosy	0.000586	0.0304	CbGpPWpGaD
Pentamidine—S100B—MyD88:Mal cascade initiated on plasma membrane—RIPK2—leprosy	0.000586	0.0304	CbGpPWpGaD
Pentamidine—Bronchitis—Thalidomide—leprosy	0.000577	0.00684	CcSEcCtD
Pentamidine—S100B—MyD88 cascade initiated on plasma membrane—NOD2—leprosy	0.000575	0.0298	CbGpPWpGaD
Pentamidine—S100B—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NOD2—leprosy	0.00057	0.0295	CbGpPWpGaD
Pentamidine—Pancytopenia—Thalidomide—leprosy	0.000569	0.00676	CcSEcCtD
Pentamidine—S100B—MyD88-independent cascade—RIPK2—leprosy	0.000562	0.0291	CbGpPWpGaD
Pentamidine—Neutropenia—Thalidomide—leprosy	0.000561	0.00665	CcSEcCtD
Pentamidine—S100B—MyD88 dependent cascade initiated on endosome—NOD2—leprosy	0.00056	0.029	CbGpPWpGaD
Pentamidine—Gastrointestinal pain—Dapsone—leprosy	0.000545	0.00646	CcSEcCtD
Pentamidine—Hyperglycaemia—Thalidomide—leprosy	0.000541	0.00642	CcSEcCtD
Pentamidine—S100B—Toll Like Receptor 9 (TLR9) Cascade—NOD2—leprosy	0.00054	0.028	CbGpPWpGaD
Pentamidine—Drowsiness—Thalidomide—leprosy	0.000534	0.00634	CcSEcCtD
Pentamidine—S100B—MyD88:Mal cascade initiated on plasma membrane—NOD2—leprosy	0.000531	0.0275	CbGpPWpGaD
Pentamidine—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00053	0.00629	CcSEcCtD
Pentamidine—Abdominal pain—Dapsone—leprosy	0.000526	0.00625	CcSEcCtD
Pentamidine—Body temperature increased—Dapsone—leprosy	0.000526	0.00625	CcSEcCtD
Pentamidine—Renal failure—Thalidomide—leprosy	0.000525	0.00624	CcSEcCtD
Pentamidine—Neuropathy peripheral—Thalidomide—leprosy	0.000524	0.00622	CcSEcCtD
Pentamidine—Stomatitis—Thalidomide—leprosy	0.000521	0.00618	CcSEcCtD
Pentamidine—Conjunctivitis—Thalidomide—leprosy	0.00052	0.00617	CcSEcCtD
Pentamidine—Haematuria—Thalidomide—leprosy	0.00051	0.00605	CcSEcCtD
Pentamidine—S100B—MyD88-independent cascade—NOD2—leprosy	0.000509	0.0264	CbGpPWpGaD
Pentamidine—S100B—Activated TLR4 signalling—RIPK2—leprosy	0.000505	0.0262	CbGpPWpGaD
Pentamidine—S100B—Activated TLR4 signalling—TLR2—leprosy	0.000505	0.0262	CbGpPWpGaD
Pentamidine—Sinusitis—Thalidomide—leprosy	0.000501	0.00595	CcSEcCtD
Pentamidine—Bradycardia—Thalidomide—leprosy	0.000488	0.0058	CcSEcCtD
Pentamidine—Rhinitis—Thalidomide—leprosy	0.000481	0.00571	CcSEcCtD
Pentamidine—Hepatitis—Thalidomide—leprosy	0.00048	0.00569	CcSEcCtD
Pentamidine—Hypoaesthesia—Thalidomide—leprosy	0.000477	0.00567	CcSEcCtD
Pentamidine—CYP1A1—skin of body—leprosy	0.000477	0.0161	CbGeAlD
Pentamidine—Pharyngitis—Thalidomide—leprosy	0.000476	0.00565	CcSEcCtD
Pentamidine—S100B—Toll Like Receptor 4 (TLR4) Cascade—TLR2—leprosy	0.000475	0.0246	CbGpPWpGaD
Pentamidine—S100B—Toll Like Receptor 4 (TLR4) Cascade—RIPK2—leprosy	0.000475	0.0246	CbGpPWpGaD
Pentamidine—Oedema peripheral—Thalidomide—leprosy	0.000473	0.00561	CcSEcCtD
Pentamidine—S100B—Activated TLR4 signalling—NOD2—leprosy	0.000458	0.0238	CbGpPWpGaD
Pentamidine—Erythema multiforme—Thalidomide—leprosy	0.000454	0.00538	CcSEcCtD
Pentamidine—S100B—Toll Like Receptor 4 (TLR4) Cascade—NOD2—leprosy	0.000431	0.0223	CbGpPWpGaD
Pentamidine—Chills—Thalidomide—leprosy	0.000431	0.00511	CcSEcCtD
Pentamidine—Arrhythmia—Thalidomide—leprosy	0.000429	0.00509	CcSEcCtD
Pentamidine—Vomiting—Dapsone—leprosy	0.000423	0.00503	CcSEcCtD
Pentamidine—S100B—Toll-Like Receptors Cascades—RIPK2—leprosy	0.000423	0.0219	CbGpPWpGaD
Pentamidine—S100B—Toll-Like Receptors Cascades—TLR2—leprosy	0.000423	0.0219	CbGpPWpGaD
Pentamidine—Headache—Dapsone—leprosy	0.000417	0.00495	CcSEcCtD
Pentamidine—Tension—Thalidomide—leprosy	0.00041	0.00486	CcSEcCtD
Pentamidine—Dysgeusia—Thalidomide—leprosy	0.000409	0.00485	CcSEcCtD
Pentamidine—Nervousness—Thalidomide—leprosy	0.000406	0.00481	CcSEcCtD
Pentamidine—Nausea—Dapsone—leprosy	0.000396	0.00469	CcSEcCtD
Pentamidine—Vision blurred—Thalidomide—leprosy	0.000394	0.00467	CcSEcCtD
Pentamidine—Tremor—Thalidomide—leprosy	0.000391	0.00464	CcSEcCtD
Pentamidine—Anaemia—Thalidomide—leprosy	0.000386	0.00458	CcSEcCtD
Pentamidine—S100B—Toll-Like Receptors Cascades—NOD2—leprosy	0.000384	0.0199	CbGpPWpGaD
Pentamidine—Angioedema—Thalidomide—leprosy	0.000382	0.00453	CcSEcCtD
Pentamidine—Vertigo—Thalidomide—leprosy	0.000375	0.00445	CcSEcCtD
Pentamidine—Syncope—Thalidomide—leprosy	0.000375	0.00445	CcSEcCtD
Pentamidine—Leukopenia—Thalidomide—leprosy	0.000374	0.00444	CcSEcCtD
Pentamidine—Palpitations—Thalidomide—leprosy	0.000369	0.00438	CcSEcCtD
Pentamidine—Loss of consciousness—Thalidomide—leprosy	0.000367	0.00436	CcSEcCtD
Pentamidine—Cough—Thalidomide—leprosy	0.000364	0.00433	CcSEcCtD
Pentamidine—Convulsion—Thalidomide—leprosy	0.000362	0.0043	CcSEcCtD
Pentamidine—Hypertension—Thalidomide—leprosy	0.000361	0.00428	CcSEcCtD
Pentamidine—Chest pain—Thalidomide—leprosy	0.000356	0.00422	CcSEcCtD
Pentamidine—Arthralgia—Thalidomide—leprosy	0.000356	0.00422	CcSEcCtD
Pentamidine—Myalgia—Thalidomide—leprosy	0.000356	0.00422	CcSEcCtD
Pentamidine—Anxiety—Thalidomide—leprosy	0.000354	0.00421	CcSEcCtD
Pentamidine—Discomfort—Thalidomide—leprosy	0.000351	0.00417	CcSEcCtD
Pentamidine—Dry mouth—Thalidomide—leprosy	0.000348	0.00413	CcSEcCtD
Pentamidine—Confusional state—Thalidomide—leprosy	0.000344	0.00408	CcSEcCtD
Pentamidine—Infection—Thalidomide—leprosy	0.000339	0.00402	CcSEcCtD
Pentamidine—Shock—Thalidomide—leprosy	0.000335	0.00398	CcSEcCtD
Pentamidine—Thrombocytopenia—Thalidomide—leprosy	0.000334	0.00396	CcSEcCtD
Pentamidine—Tachycardia—Thalidomide—leprosy	0.000333	0.00395	CcSEcCtD
Pentamidine—CYP2C8—testis—leprosy	0.000326	0.011	CbGeAlD
Pentamidine—Anorexia—Thalidomide—leprosy	0.000325	0.00386	CcSEcCtD
Pentamidine—Hypotension—Thalidomide—leprosy	0.000319	0.00378	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Thalidomide—leprosy	0.000311	0.00369	CcSEcCtD
Pentamidine—Insomnia—Thalidomide—leprosy	0.000308	0.00366	CcSEcCtD
Pentamidine—Paraesthesia—Thalidomide—leprosy	0.000306	0.00363	CcSEcCtD
Pentamidine—Dyspnoea—Thalidomide—leprosy	0.000304	0.00361	CcSEcCtD
Pentamidine—Somnolence—Thalidomide—leprosy	0.000303	0.0036	CcSEcCtD
Pentamidine—Dyspepsia—Thalidomide—leprosy	0.0003	0.00356	CcSEcCtD
Pentamidine—Decreased appetite—Thalidomide—leprosy	0.000296	0.00352	CcSEcCtD
Pentamidine—CYP1A1—nervous system—leprosy	0.000295	0.00996	CbGeAlD
Pentamidine—Fatigue—Thalidomide—leprosy	0.000294	0.00349	CcSEcCtD
Pentamidine—Constipation—Thalidomide—leprosy	0.000292	0.00346	CcSEcCtD
Pentamidine—Pain—Thalidomide—leprosy	0.000292	0.00346	CcSEcCtD
Pentamidine—Feeling abnormal—Thalidomide—leprosy	0.000281	0.00333	CcSEcCtD
Pentamidine—Gastrointestinal pain—Thalidomide—leprosy	0.000279	0.00331	CcSEcCtD
Pentamidine—Urticaria—Thalidomide—leprosy	0.000271	0.00321	CcSEcCtD
Pentamidine—Abdominal pain—Thalidomide—leprosy	0.000269	0.0032	CcSEcCtD
Pentamidine—Body temperature increased—Thalidomide—leprosy	0.000269	0.0032	CcSEcCtD
Pentamidine—Hypersensitivity—Thalidomide—leprosy	0.000251	0.00298	CcSEcCtD
Pentamidine—Asthenia—Thalidomide—leprosy	0.000245	0.0029	CcSEcCtD
Pentamidine—Pruritus—Thalidomide—leprosy	0.000241	0.00286	CcSEcCtD
Pentamidine—Diarrhoea—Thalidomide—leprosy	0.000233	0.00277	CcSEcCtD
Pentamidine—Dizziness—Thalidomide—leprosy	0.000225	0.00268	CcSEcCtD
Pentamidine—CYP2D6—testis—leprosy	0.000217	0.00733	CbGeAlD
Pentamidine—Vomiting—Thalidomide—leprosy	0.000217	0.00257	CcSEcCtD
Pentamidine—CYP3A4—nervous system—leprosy	0.000217	0.00731	CbGeAlD
Pentamidine—Rash—Thalidomide—leprosy	0.000215	0.00255	CcSEcCtD
Pentamidine—Dermatitis—Thalidomide—leprosy	0.000215	0.00255	CcSEcCtD
Pentamidine—Headache—Thalidomide—leprosy	0.000214	0.00253	CcSEcCtD
Pentamidine—CYP2D6—nervous system—leprosy	0.000213	0.0072	CbGeAlD
Pentamidine—S100B—Innate Immune System—CYLD—leprosy	0.000213	0.011	CbGpPWpGaD
Pentamidine—Nausea—Thalidomide—leprosy	0.000202	0.0024	CcSEcCtD
Pentamidine—S100B—Innate Immune System—RIPK2—leprosy	0.000137	0.00711	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—TLR2—leprosy	0.000137	0.00711	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—NOD2—leprosy	0.000124	0.00644	CbGpPWpGaD
Pentamidine—S100B—Immune System—CYLD—leprosy	0.000124	0.00643	CbGpPWpGaD
Pentamidine—S100B—Immune System—PARK2—leprosy	0.00011	0.00568	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—leprosy	0.000103	0.00534	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—leprosy	9.16e-05	0.00475	CbGpPWpGaD
Pentamidine—S100B—Immune System—RIPK2—leprosy	7.99e-05	0.00414	CbGpPWpGaD
Pentamidine—S100B—Immune System—TLR2—leprosy	7.99e-05	0.00414	CbGpPWpGaD
Pentamidine—S100B—Immune System—NOD2—leprosy	7.24e-05	0.00375	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—leprosy	6.67e-05	0.00346	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—leprosy	6.67e-05	0.00346	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—leprosy	6.57e-05	0.00341	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—SDHD—leprosy	6.26e-05	0.00325	CbGpPWpGaD
Pentamidine—S100B—Immune System—CD40LG—leprosy	6.12e-05	0.00317	CbGpPWpGaD
Pentamidine—S100B—Immune System—CD8A—leprosy	6.05e-05	0.00314	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—CD4—leprosy	5.97e-05	0.00309	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—leprosy	5.84e-05	0.00303	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—RIPK2—leprosy	5.16e-05	0.00268	CbGpPWpGaD
Pentamidine—S100B—Immune System—HLA-DRB1—leprosy	4.93e-05	0.00256	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—leprosy	4.25e-05	0.0022	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—leprosy	4.25e-05	0.0022	CbGpPWpGaD
Pentamidine—S100B—Immune System—IFNG—leprosy	3.6e-05	0.00187	CbGpPWpGaD
Pentamidine—S100B—Immune System—CD4—leprosy	3.48e-05	0.0018	CbGpPWpGaD
Pentamidine—S100B—Immune System—IL2—leprosy	3.2e-05	0.00166	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—SDHD—leprosy	2.63e-05	0.00136	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—SDHD—leprosy	2.48e-05	0.00129	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—SDHD—leprosy	2.28e-05	0.00118	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—IL2—leprosy	2.07e-05	0.00107	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—SDHD—leprosy	2.03e-05	0.00105	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—SDHD—leprosy	1.87e-05	0.000969	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—SDHD—leprosy	1.58e-05	0.000821	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SDHD—leprosy	1.22e-05	0.000634	CbGpPWpGaD
